Skip to main content
Journal of Anaesthesiology, Clinical Pharmacology logoLink to Journal of Anaesthesiology, Clinical Pharmacology
letter
. 2020 Feb 18;36(1):135–137. doi: 10.4103/joacp.JOACP_163_18

Thromboembolic complications in patients with septic shock requiring invasive mechanical ventilation: Incidence, risk factors, and outcomes

Mabrouk Bahloul 1,, Sabrine Bradai 1, Olfa Turki 1, Karama Bouchaala 1, Nadia Khlaf Bouaziz 1, Hedi Chelly 1, Sondes Haddar 2, Mounir Bouaziz 1
PMCID: PMC7047704  PMID: 32174683

Dear Editor,

Patients are at high risk for both deep vein thrombosis (DVT) and pulmonary embolism (PE) during a stay in an intensive care unit (ICU).[1,2,3,4,5] The majority of ICU patients are severely ill requiring sedation and mechanical ventilation.[4,5] However, little is known about the incidence and particularities of venous thromboembolic complications (VTE) in patients with septic shock requiring ICU admission. In the best our knowledge, only one prospective study was done on this subject showing a high incidence of VTE in patients with severe sepsis and/or septic shock, regardless of the use of universal, guideline-recommended thromboprophylaxis.[1] During the period from January 01, 2017 to December 31, 2017, we prospectively studied 60 successional enrolled patients with established septic shock in the ICU of Habib Bourguiba University Hospital, Tunisia. Patients that were recruited in the study included those that developed septic shock as a result of bacterial infection during the study period. Thromboprophylaxis was recorded for all patients. Spiral computed tomography scan and venous compression ultrasound were used to confirm the diagnosis of thromboembolic complications (TEC). PE is suspected by the presence of un-explicated hypoxemia and/or shock as well as arterial hypotension during diagnosis in our institution, and spiral computed tomography is used for PE confirmation. However, venous compression ultrasound is performed when thepatient developed clinical features of thrombophlebitis and/or when thereare contraindications of spiral computed tomography.

During the study period, 24 patients (40%) developed VTE complications, despite all patients receiving guideline-recommended thromboprophylaxis. Mean Simplified Acute Physiology Score II (SAPSII score),[6] which isintended to evaluate the severity of disease for patients admitted to Intensive care units aged 15 or more, was significantly higher in the thromboembolic complications free group [Table 1].

Table 1.

Comparison between the two groups (with and without VTE)

Characteristic VTE Group (n=24) VTE-FREE Group (n=36) P
Age (years) 51.8±16.4 45.1±20.3 0.183
Sex ratio (M/F) 21/3 25/11 0.105
SAPS II on ICU admission 35.3±14.5 44.3±16.2 0.032
SOFA 5.5±1.3 8±4.1 0.017
GCS on ICU admission 10.6±4 9.5±4.3 0.329
Type of admission:
 Medical 10 22
 Traumatism 11 11 0.335
 Surgical 3 3
Duration of mechanical ventilation (days) 32.7±11.4 12.9±9.3 <0.001
Tracheotomy 23 23 0.004
DIC 6 17 0.083
Acute kidneyfailure 18 23 0.365
Dialysis 2 13 0.015
Length of stay (days) 37.3±11.6 16.3±11.7 <0.001
Mortality rate 58.3% 63.9% 0.665
pH on ICU admission 7.39±0.09 7.37±0.10 0.740
PACO2 (mmHg) on ICU admission 38.13±8.38 37.45±9.66 0.779
PAO2/FiO2 ratio on ICU admission 270±112.8 267.4±109.8 0.931
HCO3- (mmol/l) on ICU admission 22.47±4.41 21.88±6.10 0.751
Troponin (ngl/l) 0.079±0.086 0.57±1.03 0.869
SGOT (UI/l) 71.4±59.3 91.5±142.6 0.952
SGPT (UI/l) 57.6±65.8 54.3±55.5 0.922
Bilirubin(μmol/l) 45.9±51.1 56.4±118.6 0.717
Blood urea (mmol/l) 12.4±7.5 17±16 0.763
Blood creatinine (μmol/l) 109±72 157±126 0.381
CRP (mg/L) 231.9±103 230±138 0.594
Procalcitonin (ng/mL) 14.6±20.9 11.3±15.5 0.682
SChEA (UI/L) 3391±1430 3423±1151 0.922

VTE=Venousthromboembolism, GCS=Glasgow coma scale score, SAPSII=Simplified acute physiology score, DIC=Disseminatedintra-vascularcoagulation, SOFA score=Sepsis-related Organ Failure Assessment score, SGOT=Sérum Glutamooxaloacétate Transférase, SGPT=Sérum Glutamopyruvate Transférase, SChEA=Serum CholinesteraseActivity

VTE was found to be associated with prolonged ICU stay and longer mechanical ventilation. However, the mortality rate was not significantly higher in patients with acutethromboembolic complications [Table 1].

Critically ill patients are usually at high risk for PE and DVT. Also, TEC is a crucial challenge these patients face. Moreover, septic shock is considered a risk factor for VTE, including upper and lower extremity DVT and pulmonary embolism (PE).[1,2] The underlying pathogenesis of VTE in sepsis remains incompletely understood but is believed to be the result of multiple factors. In addition to risk factors for hypercoagulability, as originally described by Virchow, incorporating the 3 original triad (stasis; endothelial injury; and hypercoagulability), severe inflammation observed in patient with sepsis and/or septic shock represents the fourth factor for thromboembolic complications.[1] Inflammation increases pro-coagulant factors, and also inhibits natural anticoagulant pathways and fibrinolytic activity, leading to DVT and PE.[2] In fact, the inflammatory process initiated by septic shock may be strained by coexisting tissue hypoxia and systemic inflammation leading to endothelial damages and DVT complications.

Our study confirms the high incidence of TEC (37.2%) in patients with sepsis despite the use of universal, guideline-recommended thromboprophylaxis reported by Kaplan et al.[1] As aconsequence, itunderlines that current recommendations of VTE prophylaxis strategies may not be as efficient and should be revised in severe sepsis and septic shock compared withnon-septic-critically ill patients. As a matter offact, it is clear that the preventive dose used of unfractionated heparin (equivalent of 40mg of enoxaparine) in our ICU, is not sufficient and must be revised in this specific condition. Therefore, to improve the prevention of VTE in patients with severe sepsis and septic shock, other clinical trials specifically studying thromboprophylaxis in patients with severe sepsis and septic shock are advised.

In our study, the comparison between the TEC (+) group and TEC free group, showed that the development of this complication was not associated with a high mortality rate. However, the development of TEC was associated with increased length of stay and longer mechanical ventilation. Our study confirms the results of previously reported studies[1,3,4,5] and underlines the importance to prevent this type of complications.

We concluded that patients with sepsis and/or septic shock are considered at high risk for developing VTE. It is the result of multiple factors including immobility, activation of thrombo-inflammatory pathways and disseminated intravascular coagulation. The development of TEC was associated with increased length of stay and longer mechanical ventilation. Thus, more effective VTE prevention strategies are necessary for patients with sepsis and/or septic shock.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  • 1.Kaplan D, Casper TC, Elliott CG, Men S, Pendleton RC, Kraiss LW, et al. VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest. 2015;148:1224–30. doi: 10.1378/chest.15-0287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Holley AD, Reade MC. The 'procoagulopathy' of trauma: Too much, too late? Curr Opin Crit Care. 2013;19:578–86. doi: 10.1097/MCC.0000000000000032. [DOI] [PubMed] [Google Scholar]
  • 3.Bahloul M, Chelly H, Regaieg K, Rekik N, Bellil S, Chaari A, et al. Pulmonary embolism following severe traumatic brain injury: Incidence, risk factors and impact outcome. Intensive Care Med. 2017;43:1433–5. doi: 10.1007/s00134-017-4815-z. [DOI] [PubMed] [Google Scholar]
  • 4.Bahloul M, Chaari A, Kallel H, Abid L, Hamida CB, Dammak H, et al. Pulmonary embolism in intensive care unit: Predictive factors, clinical manifestations and outcome. Ann Thorac Med. 2010;5:97–103. doi: 10.4103/1817-1737.62473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bahloul M, Chaari A, Tounsi A, Baccouche N, Abid H, Chtara K, et al. Incidence and impact outcome of pulmonary embolism in critically ill patients with severe exacerbation of chronic obstructive pulmonary diseases. Clin Respir J. 2015;9:270–7. doi: 10.1111/crj.12131. [DOI] [PubMed] [Google Scholar]
  • 6.Moreau R, Soupison T, Vauquelin P, Derrida S, Beaucour H, Sicot C. Comparison of two simplified severity scores (SAPS and APACHE II) for patients with acute myocardial infarction. Crit Care Med. 1989;17:409–13. doi: 10.1097/00003246-198905000-00006. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Anaesthesiology, Clinical Pharmacology are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES